20 results
10-Q
2021 Q2
VERV
Verve Therapeutics Inc
12 Aug 21
Quarterly report
8:53am
differences between preliminary or interim data and final data could be material and could significantly harm our reputation and business prospects and may … reputation and resulting harm to physician or patient acceptance of our products.
Any of these events could prevent us from achieving or maintaining
S-1
l68xctex
28 May 21
IPO registration
4:04pm
10-K
4nrx8eu jm6ep
14 Mar 22
Annual report
7:04am
424B4
6hodfab8fhjcj tkbmh
17 Jun 21
Prospectus supplement with pricing info
4:50pm
DRS
5u8jv
16 Apr 21
Draft registration statement
12:00am
S-1/A
w6w1v74 2fok
14 Jun 21
IPO registration (amended)
6:15am
DEF 14A
pjnh vushh503ix4nli
29 Apr 22
Definitive proxy
7:01am
- Prev
- 1
- Next